Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints
Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints
Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints
Submitted by
admin
on December 17, 2013 - 9:37am
Source:
Yahoo/Fly on the Wall
News Tags:
Amgen
evolocumab
cholesterol
Headline:
Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints
Do Not Allow Advertisers to Use My Personal information
